Global Nanoemulsions 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI01250647

Publication Date:

January 17, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Nanoemulsions market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Emulsion is the process of suspension of small globules of one liquid into other such that the fluids are immiscible with each other. Nanoemulsions are the group of dispersed nano-particles of oil in water having extremely minute size of 100-600 nm. The nanoemulsions are prepared using various emulsification techniques such as microfluidization, high-pressure homogenization and sonication (use of ultrasound energy).
There are several advantages of nanoemulsions over the conventional emulsion systems. One of the major advantages is the extreme micro droplet size of nanoemulsions with much high surface area which makes them highly effective in transportation system or delivery systems used majorly in cosmetics. Moreover, nanoparticles do not cause the problems such as flocculation, coalescence or inherent creaming which are generally faced by microemulsions. This makes nanoemulsions ideal for variety of formulations such creams, sprays and foams.

Considering the extreme small size of these particles, the nanoemulsions are increasingly finding application in pharmaceutical industry, cosmetic industry and also in food sector. The pharmaceutical applications of nanoemulsions majorly dominate the nanoemulsions market, followed by the cosmetic usages. Currently, the market for nanoemulsions is dominated by North America and Europe. Asia Pacific is the fastest growing market for nanoemulsions.
In USA, EU, Japan, China, India and Southeast Asia, Nanoemulsions key players include Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, etc.
USA is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent.
In terms of application, the largest application is Pharmaceutical Industrial, with a share over 45%, followed by Cosmetic Industrial, Food Industrial, etc.
The 鈥淣anoemulsions Industry Forecast鈥� looks at past sales and reviews total world Nanoemulsions sales in 2024, providing a comprehensive analysis by region and market sector of projected Nanoemulsions sales for 2025 through 2031. With Nanoemulsions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nanoemulsions industry.
This Insight Report provides a comprehensive analysis of the global Nanoemulsions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nanoemulsions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Nanoemulsions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nanoemulsions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nanoemulsions.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanoemulsions market by product type, application, key players and key regions and countries.
Segmentation by Type:
Steroids
Anesthetics
NSAIDs
Immunosuppressant
Antiretroviral
Antimicrobials
Vasodilators
Others
Segmentation by Application:
Pharmaceutical Industrial
Cosmetic Industrial
Food Industrial
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Allergan plc
AbbVie Inc.
AstraZeneca Inc.
Fresenius Kabi AG
Kaken Pharmaceutical
GlaxoSmithKline
Novartis AG
Sanofi
B. Braun Melsungen

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Nanoemulsions 麻豆原创 Size (2020-2031)
2.1.2 Nanoemulsions 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Nanoemulsions by Country/Region (2020, 2024 & 2031)
2.2 Nanoemulsions Segment by Type
2.2.1 Steroids
2.2.2 Anesthetics
2.2.3 NSAIDs
2.2.4 Immunosuppressant
2.2.5 Antiretroviral
2.2.6 Antimicrobials
2.2.7 Vasodilators
2.2.8 Others
2.3 Nanoemulsions 麻豆原创 Size by Type
2.3.1 Nanoemulsions 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Nanoemulsions 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Nanoemulsions Segment by Application
2.4.1 Pharmaceutical Industrial
2.4.2 Cosmetic Industrial
2.4.3 Food Industrial
2.4.4 Others
2.5 Nanoemulsions 麻豆原创 Size by Application
2.5.1 Nanoemulsions 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Nanoemulsions 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Nanoemulsions 麻豆原创 Size by Player
3.1 Nanoemulsions 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Nanoemulsions Revenue by Player (2020-2025)
3.1.2 Global Nanoemulsions Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Nanoemulsions Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanoemulsions by Region
4.1 Nanoemulsions 麻豆原创 Size by Region (2020-2025)
4.2 Global Nanoemulsions Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nanoemulsions 麻豆原创 Size Growth (2020-2025)
4.4 APAC Nanoemulsions 麻豆原创 Size Growth (2020-2025)
4.5 Europe Nanoemulsions 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Nanoemulsions 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Nanoemulsions 麻豆原创 Size by Country (2020-2025)
5.2 Americas Nanoemulsions 麻豆原创 Size by Type (2020-2025)
5.3 Americas Nanoemulsions 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nanoemulsions 麻豆原创 Size by Region (2020-2025)
6.2 APAC Nanoemulsions 麻豆原创 Size by Type (2020-2025)
6.3 APAC Nanoemulsions 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nanoemulsions 麻豆原创 Size by Country (2020-2025)
7.2 Europe Nanoemulsions 麻豆原创 Size by Type (2020-2025)
7.3 Europe Nanoemulsions 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nanoemulsions by Region (2020-2025)
8.2 Middle East & Africa Nanoemulsions 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Nanoemulsions 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Nanoemulsions 麻豆原创 Forecast
10.1 Global Nanoemulsions Forecast by Region (2026-2031)
10.1.1 Global Nanoemulsions Forecast by Region (2026-2031)
10.1.2 Americas Nanoemulsions Forecast
10.1.3 APAC Nanoemulsions Forecast
10.1.4 Europe Nanoemulsions Forecast
10.1.5 Middle East & Africa Nanoemulsions Forecast
10.2 Americas Nanoemulsions Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Nanoemulsions Forecast
10.2.2 Canada 麻豆原创 Nanoemulsions Forecast
10.2.3 Mexico 麻豆原创 Nanoemulsions Forecast
10.2.4 Brazil 麻豆原创 Nanoemulsions Forecast
10.3 APAC Nanoemulsions Forecast by Region (2026-2031)
10.3.1 China Nanoemulsions 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Nanoemulsions Forecast
10.3.3 Korea 麻豆原创 Nanoemulsions Forecast
10.3.4 Southeast Asia 麻豆原创 Nanoemulsions Forecast
10.3.5 India 麻豆原创 Nanoemulsions Forecast
10.3.6 Australia 麻豆原创 Nanoemulsions Forecast
10.4 Europe Nanoemulsions Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Nanoemulsions Forecast
10.4.2 France 麻豆原创 Nanoemulsions Forecast
10.4.3 UK 麻豆原创 Nanoemulsions Forecast
10.4.4 Italy 麻豆原创 Nanoemulsions Forecast
10.4.5 Russia 麻豆原创 Nanoemulsions Forecast
10.5 Middle East & Africa Nanoemulsions Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Nanoemulsions Forecast
10.5.2 South Africa 麻豆原创 Nanoemulsions Forecast
10.5.3 Israel 麻豆原创 Nanoemulsions Forecast
10.5.4 Turkey 麻豆原创 Nanoemulsions Forecast
10.6 Global Nanoemulsions Forecast by Type (2026-2031)
10.7 Global Nanoemulsions Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Nanoemulsions Forecast
11 Key Players Analysis
11.1 Allergan plc
11.1.1 Allergan plc Company Information
11.1.2 Allergan plc Nanoemulsions Product Offered
11.1.3 Allergan plc Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Allergan plc Main Business Overview
11.1.5 Allergan plc Latest Developments
11.2 AbbVie Inc.
11.2.1 AbbVie Inc. Company Information
11.2.2 AbbVie Inc. Nanoemulsions Product Offered
11.2.3 AbbVie Inc. Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 AbbVie Inc. Main Business Overview
11.2.5 AbbVie Inc. Latest Developments
11.3 AstraZeneca Inc.
11.3.1 AstraZeneca Inc. Company Information
11.3.2 AstraZeneca Inc. Nanoemulsions Product Offered
11.3.3 AstraZeneca Inc. Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 AstraZeneca Inc. Main Business Overview
11.3.5 AstraZeneca Inc. Latest Developments
11.4 Fresenius Kabi AG
11.4.1 Fresenius Kabi AG Company Information
11.4.2 Fresenius Kabi AG Nanoemulsions Product Offered
11.4.3 Fresenius Kabi AG Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Fresenius Kabi AG Main Business Overview
11.4.5 Fresenius Kabi AG Latest Developments
11.5 Kaken Pharmaceutical
11.5.1 Kaken Pharmaceutical Company Information
11.5.2 Kaken Pharmaceutical Nanoemulsions Product Offered
11.5.3 Kaken Pharmaceutical Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Kaken Pharmaceutical Main Business Overview
11.5.5 Kaken Pharmaceutical Latest Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Information
11.6.2 GlaxoSmithKline Nanoemulsions Product Offered
11.6.3 GlaxoSmithKline Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 GlaxoSmithKline Main Business Overview
11.6.5 GlaxoSmithKline Latest Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Nanoemulsions Product Offered
11.7.3 Novartis AG Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Novartis AG Main Business Overview
11.7.5 Novartis AG Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Nanoemulsions Product Offered
11.8.3 Sanofi Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 B. Braun Melsungen
11.9.1 B. Braun Melsungen Company Information
11.9.2 B. Braun Melsungen Nanoemulsions Product Offered
11.9.3 B. Braun Melsungen Nanoemulsions Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 B. Braun Melsungen Main Business Overview
11.9.5 B. Braun Melsungen Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.